156 related articles for article (PubMed ID: 35088964)
1. [Factors Influencing Pneumococcal Vaccination-Induced Total IgG, IgG2, and IgA Levels in Vaccinated Splenectomized Patients].
Gazi U; Derici MK; Karasartova D; Güreser AS; Şahiner İT; Dolapçı M; Taylan Özkan A
Mikrobiyol Bul; 2022 Jan; 56(1):103-113. PubMed ID: 35088964
[TBL] [Abstract][Full Text] [Related]
2. A prospective study on antibody response to repeated vaccinations with pneumococcal capsular polysaccharide in splenectomized individuals with special reference to Hodgkin's lymphoma.
Landgren O; Björkholm M; Konradsen HB; Söderqvist M; Nilsson B; Gustavsson A; Axdorph U; Kalin M; Grimfors G
J Intern Med; 2004 Jun; 255(6):664-73. PubMed ID: 15147530
[TBL] [Abstract][Full Text] [Related]
3. A longitudinal study of class and subclass antibody response to pneumococcal vaccination in splenectomized individuals with special reference to patients with Hodgkin's disease.
Grimfors G; Söderqvist M; Holm G; Lefvert AK; Björkholm M
Eur J Haematol; 1990 Aug; 45(2):101-8. PubMed ID: 2209812
[TBL] [Abstract][Full Text] [Related]
4. Type-specific anti-pneumococcal antibody subclass response to vaccination after splenectomy with special reference to lymphoma patients.
Grimfors G; Björkholm M; Hammarström L; Askergren J; Smith CI; Holm G
Eur J Haematol; 1989 Nov; 43(5):404-10. PubMed ID: 2612613
[TBL] [Abstract][Full Text] [Related]
5. The total IgM, IgA and IgG antibody responses to pneumococcal polysaccharide vaccination (Pneumovax®23) in a healthy adult population and patients diagnosed with primary immunodeficiencies.
Parker AR; Park MA; Harding S; Abraham RS
Vaccine; 2019 Feb; 37(10):1350-1355. PubMed ID: 30737041
[TBL] [Abstract][Full Text] [Related]
6. Immune response to pneumococcal conjugate vaccination in asplenic individuals.
Stanford E; Print F; Falconer M; Lamden K; Ghebrehewet S; Phin N; Baxter D; Helbert M; McCann R; Andrews N; Balmer P; Borrow R; Kaczmarski E
Hum Vaccin; 2009 Feb; 5(2):85-91. PubMed ID: 18758242
[TBL] [Abstract][Full Text] [Related]
7. IgG subclass antibody responses to pneumococcal polysaccharide vaccine in splenectomized, otherwise normal, individuals.
Aaberge IS; Michaelsen TE; Heier HE
Scand J Immunol; 1990 Jun; 31(6):711-6. PubMed ID: 2356437
[TBL] [Abstract][Full Text] [Related]
8. Pneumococcal Conjugate Vaccine Does Not Induce Humoral Response When Administrated Within the Six Months After CD19 CAR T-Cell Therapy.
Lee D; Jordan AI; Menges MA; Lazaryan A; Nishihori T; Gaballa SR; Shah BD; Pinilla-Ibarz J; Baluch A; Klinkova OV; Chavez JC; Jain MD; Locke FL
Transplant Cell Ther; 2023 Apr; 29(4):277.e1-277.e9. PubMed ID: 35970303
[TBL] [Abstract][Full Text] [Related]
9. Timing of vaccination does not affect antibody response or survival after pneumococcal challenge in splenectomized rats.
Schreiber MA; Pusateri AE; Veit BC; Smiley RA; Morrison CA; Harris RA
J Trauma; 1998 Oct; 45(4):692-7; discussion 697-9. PubMed ID: 9783606
[TBL] [Abstract][Full Text] [Related]
10. Vaccination status and immune response to 13-valent pneumococcal conjugate vaccine in asplenic individuals.
Nived P; Jørgensen CS; Settergren B
Vaccine; 2015 Mar; 33(14):1688-94. PubMed ID: 25707692
[TBL] [Abstract][Full Text] [Related]
11. Anti-Pneumococcal Vaccine-Induced Cellular Immune Responses in Post-Traumatic Splenectomized Individuals.
Karasartova D; Gazi U; Tosun O; Gureser AS; Sahiner IT; Dolapci M; Ozkan AT
J Clin Immunol; 2017 May; 37(4):388-396. PubMed ID: 28488145
[TBL] [Abstract][Full Text] [Related]
12. Deficient IgA and IgG2 anti-pneumococcal antibody levels and response to vaccination in otitis prone children.
Dhooge IJ; van Kempen MJ; Sanders LA; Rijkers GT
Int J Pediatr Otorhinolaryngol; 2002 Jun; 64(2):133-41. PubMed ID: 12049826
[TBL] [Abstract][Full Text] [Related]
13. IgM and IgG response to pneumococcal polysaccharide vaccine in normal individuals and individuals splenectomized due to trauma.
Aaberge IS; Heier HE; Hem E; Giercksky KE; Groeng EC
Acta Pathol Microbiol Immunol Scand C; 1984 Feb; 92(1):11-6. PubMed ID: 6711306
[TBL] [Abstract][Full Text] [Related]
14. Spleen autotransplantation provides restoration of functional splenic lymphoid compartments and improves the humoral immune response to pneumococcal polysaccharide vaccine.
Leemans R; Harms G; Rijkers GT; Timens W
Clin Exp Immunol; 1999 Sep; 117(3):596-604. PubMed ID: 10469068
[TBL] [Abstract][Full Text] [Related]
15. Immune responses of splenectomized trauma patients to the 23-valent pneumococcal polysaccharide vaccine at 1 versus 7 versus 14 days after splenectomy.
Shatz DV; Schinsky MF; Pais LB; Romero-Steiner S; Kirton OC; Carlone GM
J Trauma; 1998 May; 44(5):760-5; discussion 765-6. PubMed ID: 9603075
[TBL] [Abstract][Full Text] [Related]
16. Serum antibody responses to vaccination with 23-valent pneumococcal vaccine in splenectomized patients.
Reinert RR; Kaufhold A; Kühnemund O; Lütticken R
Zentralbl Bakteriol; 1994 Nov; 281(4):481-90. PubMed ID: 7727895
[TBL] [Abstract][Full Text] [Related]
17. IgG and IgM antibody responses to pneumococcal vaccination in splenectomized children and in children who had non-operative management of splenic rupture.
Kalin M; Linné T; Eriksson M; Lännergren K; Tordal P; Jakobsson B; Lundmark KM
Acta Paediatr Scand; 1986 May; 75(3):452-6. PubMed ID: 3728005
[TBL] [Abstract][Full Text] [Related]
18. Preserved antibody levels and loss of memory B cells against pneumococcus and tetanus after splenectomy: tailoring better vaccination strategies.
Rosado MM; Gesualdo F; Marcellini V; Di Sabatino A; Corazza GR; Smacchia MP; Nobili B; Baronci C; Russo L; Rossi F; Vito RD; Nicolosi L; Inserra A; Locatelli F; Tozzi AE; Carsetti R
Eur J Immunol; 2013 Oct; 43(10):2659-70. PubMed ID: 23813052
[TBL] [Abstract][Full Text] [Related]
19. Efficacy, immunogenicity, and evidence for best-timing of pneumococcal vaccination in splenectomized adults: a systematic review.
Lenzing E; Rezahosseini O; Burgdorf SK; Nielsen SD; Harboe ZB
Expert Rev Vaccines; 2022 May; 21(5):723-733. PubMed ID: 35236233
[TBL] [Abstract][Full Text] [Related]
20. Pneumococcal vaccination for splenectomized patients with thalassemia major in Indonesia.
Sari TT; Akib AAP; Gatot D; Roswita Harahap A; Bardosono S; Hadinegoro SRS
Vaccine; 2017 Aug; 35(35 Pt B):4583-4586. PubMed ID: 28712490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
